Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.38%
#2 Victoria VR Victoria VR +11.93%
#3 Palladium Network Palladium Network +9.28%
#4 Movement Movement +8.40%
#5 DMT-NAT DMT-NAT +6.25%
#6 Cryptopia Cryptopia +4.73%
#7 Pons Pons +4.23%
#8 GRVT Token GRVT Token +3.85%
#9 MarsCoin MarsCoin +3.69%
#10 COTI COTI +3.65%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Evolutionary Genomics, Inc. Evolutionary Genomics, Inc.

Evolutionary Genomics, Inc.

FNAM
Classifica tra le azioni #42444
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the... Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.
Prezzo delle azioni
$0.0002
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$1.33K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Evolutionary Genomics, Inc. (FNAM)

Categoria

Healthcare
Storico del prezzo dell'azione per Evolutionary Genomics, Inc. (FNAM)
Prezzo di chiusura più alto: $0.00 il 2026-08-01

Prezzo di chiusura più basso: $15.63 il 2012-05-01
Storico del prezzo dell'azione di Evolutionary Genomics, Inc. dal 2012 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 0.00%
2025 -75.00%
2024 -99.82%
2023 -35.71%
2022 -3.81%
2021 -19.83%
2020 -43.50%
2019 542.67%
2018 -75.05%
2017 -71.37%
2016 40.00%
2015 -80.44%
2014 7.12%
2013 90.95%
2012 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.44%
KR